Access to medicines in the context of the right-to-health framework 2013, para. 18
Párrafo- Paragraph text
- In complying with their obligation to ensure availability of medicines, States may consider the following policy options to develop an enabling environment that promotes the growth of local pharmaceutical industry: (i) levying taxes on imports of medicines that can be locally produced, except for active pharmaceutical ingredients which are generally not imported; (ii) providing subsidies; (iii) tax incentives; (iv) guaranteed government procurement to local manufacturers; and (v) a regulatory framework to increase local competitiveness. As highlighted during the Special Rapporteur's consultations, local production of medicines has indirect benefits, such as (i) promoting transfer of technology (ii) providing employment and capacity-building of local people through training programmes for local pharmacists (ii) microbiologists and technicians, and (iii) setting up local institutes of higher education and contributing to capacity-building of the regulatory agencies. Thus, opting for local generic production should be weighed and balanced against a number of benefits, including strategic security in medicines supply, which would be achieved in the long run as opposed to the higher prices in the short run.
- Condicón jurídica
- Non-negotiated soft law
- Organismo
- Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health
- Tipo de documento
- Special Procedures' report
- Medio de adopción
- N.A.
- Temas
- Health
- Personas afectadas
- N.A.
- Año
- 2013
- Tipo de párrafo
- Other
- Reference
- SR Health, Report to the HRC (2013), A/HRC/23/42, para. 18.
- Paragraph number
- 18
ordenados por
Fecha de adición
90 conexiones, 90 Entidades